Cargando…

Myo-Inositol’s Role in Assisted Reproductive Technology: Evidence for Improving the Quality of Oocytes and Embryos in Patients With Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is one of the most common causes of subfertility, and it is characterized by hormonal dysregulation like insulin resistance. Various measures have been taken in the past to overcome this insulin resistance to improve fertility treatment outcomes. The current paper ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Deepti, Khan, Safeera, Islam, Muhammad, Malik, Bilal Haider, Rutkofsky, Ian H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292722/ https://www.ncbi.nlm.nih.gov/pubmed/32542134 http://dx.doi.org/10.7759/cureus.8079

Ejemplares similares

Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
por: Merviel, Philippe, et al.
Publicado: (2021)

Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
por: Kamenov, Zdravko, et al.
Publicado: (2023)

Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial
por: Bahadur, Anupama, et al.
Publicado: (2021)

Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome
por: Raj, Deepak, et al.
Publicado: (2021)

Type 2 Diabetes Mellitus in Patients With Polycystic Ovary Syndrome
por: Agrawal, Anjali, et al.
Publicado: (2023)

Mediator in the Embryo-endometrium Cross-talk: Granulocyte Colony-stimulating Factor in Infertility
por: Robert, Chris A, et al.
Publicado: (2019)

Polycystic Ovary Syndrome Among Female Adolescents With Congenital Adrenal Hyperplasia
por: Abdelhamed, Marwa H, et al.
Publicado: (2021)

Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association
por: Shetty, Chaitra, et al.
Publicado: (2023)

New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome
por: Saleem, Fatima, et al.
Publicado: (2017)

Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review
por: Peddemul, Aishwarya, et al.
Publicado: (2022)

Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
por: Layacha, Sakshi Y, et al.
Publicado: (2023)

Why are Women With Polycystic Ovary Syndrome at Increased Risk of Depression? Exploring the Etiological Maze
por: Gnawali, Anupa, et al.
Publicado: (2021)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: A Literature Review With a Focus on Diagnosis, Pathophysiology, and Management
por: Waghmare, Shrutika V, et al.
Publicado: (2023)

The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to Birth
por: Russo, Michele, et al.
Publicado: (2021)

Frank’s Sign in Polycystic Ovary Syndrome and Sideburn Adiposity: A Case Report and Illustrated Hypothesis
por: Abrahim, Mohammed
Publicado: (2021)

Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study
por: Mishra, Neha, et al.
Publicado: (2022)

The Effect of Insulin Resistance on Ovulation Induction With Clomiphene Citrate in Non-polycystic Ovary Syndrome (PCOS) Women
por: Karnatak, Ruchi, et al.
Publicado: (2022)

Effects of Metformin on Symptoms of Polycystic Ovarian Syndrome Among Women of Reproductive Age
por: Artani, Moiz, et al.
Publicado: (2018)

Idiopathic Hyperprolactinemia Presenting as Polycystic Ovary Syndrome in Identical Twin Sisters: A Case Report and Literature Review
por: Goyal, Alpesh, et al.
Publicado: (2018)

Myoinositol Versus Metformin in the Treatment of Polycystic Ovarian Syndrome: A Systematic Review
por: Bodepudi, Ranita, et al.
Publicado: (2023)

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022)

Development of the First Health-Related Quality of Life Questionnaires in Arabic for Women with Polycystic Ovary Syndrome (Part I): The Creation and Reliability Analysis of PCOSQoL-47 and PCOSQoL-42 Questionnaires
por: Odhaib, Samih A, et al.
Publicado: (2021)

Development of the First Health-Related Quality of Life Questionnaires in Arabic for Women With Polycystic Ovary Syndrome (Part II): Dual-Center Validation of PCOSQoL-47 and PCOSQoL-42 Questionnaires
por: Odhaib, Samih A, et al.
Publicado: (2021)

Comparison of Serum Vitamin B12 Levels Among Drug-Naïve and Metformin-Treated Patients With Polycystic Ovary Syndrome
por: Kamrul-Hasan, ABM, et al.
Publicado: (2022)

Evaluation of the Salivary Matrix Metalloproteinase-9 in Women With Polycystic Ovaries Syndrome and Gingival Inflammation: A Case-Control Study
por: Maboudi, Avideh, et al.
Publicado: (2023)

Association Between Follicle-Stimulating Hormone Receptor (FSHR) rs6166 and Estrogen Receptor 1 (ESR1) rs2234693 Polymorphisms and Polycystic Ovary Syndrome Risk, Phenotype, and Reproductive Outcomes in an Infertile Portuguese Population
por: Vieira, Inês H, et al.
Publicado: (2023)

Clinical Presentation and Frequency of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: An Experience From a Tertiary Care Hospital in Pakistan
por: Anjum, Sarwat, et al.
Publicado: (2020)

Effect of Prebiotic Dietary Supplement Acacia senegal on Hormonal and Metabolic Markers in Polycystic Ovary Syndrome Patients: A Pilot Study
por: Mohamed, Reem I, et al.
Publicado: (2023)

Development of the First Health-Related Quality of Life Questionnaires in Arabic for Women With Polycystic Ovary Syndrome (Part III): Scoring System Interpretation
por: Odhaib, Samih A, et al.
Publicado: (2022)

Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial
por: Ibrahim, Ibrahim, et al.
Publicado: (2022)

Correlation of Cutaneous Manifestations With Body Mass Index (BMI) in Polycystic Ovary Syndrome (PCOS) Patients in a Tertiary Care Centre: An Observational Study
por: Jena, Pramila, et al.
Publicado: (2021)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Etiological Association Between Psoriasis and Thyroid Diseases
por: Eapi, Srilatha, et al.
Publicado: (2021)

Polycystic Ovarian Syndrome in Adolescents
por: Adone, Avanti, et al.
Publicado: (2023)

PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
por: Monastra, Giovanni, et al.
Publicado: (2021)

Insulin Resistance in Polycystic Ovarian Syndrome
por: Purwar, Ananya, et al.
Publicado: (2022)

Iodine and Myo-Inositol: A Novel Promising Combination for Iodine Deficiency
por: Barbaro, Daniele, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kqqjin7m5mdscqkhrm7dhi975d